Literature DB >> 33429896

Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients.

Piotr K Krajewski1, Łukasz Matusiak1, Esther von Stebut2, Michael Schultheis3, Uwe Kirschner4, Georgios Nikolakis5, Jacek C Szepietowski1.   

Abstract

The chronic, inflammatory skin disorder hidradenitis suppurativa (HS) is associated well documented negative influences on patients' quality of life (QoL). The aim of this study was to present more robust data on patients' QoL impairment by demographic data and its correlation with well-known HS risk factors on a cohort of 1795 German patients. The instrument used for measuring QoL in this study was the Dermatology Life Quality Index (DLQI). Overall, patients reported a very large effect of HS on their QoL (mean DLQI: 13.2 ± 8.1 points), and 22% of the analyzed population even reported to consider the effect as extremely large. Women tended to experience significantly higher impairment than men (p < 0.001). QoL impairment correlated positively with pain (r = 0.581, p < 0.001), HS severity (measured by the International Hidradenitis Suppurativa Severity Score System (IHS4)) as well as Hurley. Neck involvement tended to decrease QoL significantly more than any other location (14.7 ± 8.3 points). This study confirms the enormous influence of HS on patients' QoL in a large cohort. Knowledge of QoL impairment in such patients is crucial for proper understanding and holistic management of this disease.

Entities:  

Keywords:  DLQI; hidradenitis suppurativa; quality of life

Year:  2021        PMID: 33429896      PMCID: PMC7828046          DOI: 10.3390/life11010034

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  47 in total

Review 1.  Alopecia areata and health-related quality of life: a systematic review and meta-analysis.

Authors:  F Rencz; L Gulácsi; M Péntek; N Wikonkál; P Baji; V Brodszky
Journal:  Br J Dermatol       Date:  2016-07-02       Impact factor: 9.302

Review 2.  Sex differences in neuroimmunity and pain.

Authors:  Sarah Rosen; Boram Ham; Jeffrey S Mogil
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

3.  Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.

Authors:  P V Chernyshov; C C Zouboulis; L Tomas-Aragones; G B Jemec; A Svensson; L Manolache; T Tzellos; F Sampogna; N Pustisek; H H van der Zee; S E Marron; S Spillekom-van Koulil; A Bewley; D Linder; D Abeni; J C Szepietowski; M Augustin; A Y Finlay
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-04-29       Impact factor: 6.166

4.  Morbidity in patients with hidradenitis suppurativa.

Authors:  J M von der Werth; G B Jemec
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

5.  Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa.

Authors:  Anargyros Kouris; Eftychia Platsidaki; Christos Christodoulou; Vasiliki Efstathiou; Clio Dessinioti; Vasiliki Tzanetakou; Panagiota Korkoliakou; Chrisa Zisimou; Christina Antoniou; George Kontochristopoulos
Journal:  Dermatology       Date:  2017-01-05       Impact factor: 5.366

Review 6.  Atopic Dermatitis, Depression, and Suicidality.

Authors:  Mathew N Nicholas; Melinda J Gooderham
Journal:  J Cutan Med Surg       Date:  2017-01-09       Impact factor: 2.092

7.  Sex differences in psychological response to pain in patients with fibromyalgia syndrome.

Authors:  Mélanie Racine; Elena Castarlenas; Rocío de la Vega; Catarina Tomé-Pires; Ester Solé; Jordi Miró; Mark P Jensen; Dwight E Moulin; Warren R Nielson
Journal:  Clin J Pain       Date:  2015-05       Impact factor: 3.442

8.  Pain perception in patients with hidradenitis suppurativa.

Authors:  R M Nielsen; P Lindsø Andersen; V Sigsgaard; P Theut Riis; G B Jemec
Journal:  Br J Dermatol       Date:  2019-07-08       Impact factor: 9.302

9.  Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis.

Authors:  D Revicki; M K Willian; J-H Saurat; K A Papp; J-P Ortonne; C Sexton; A Camez
Journal:  Br J Dermatol       Date:  2007-11-28       Impact factor: 9.302

10.  Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study.

Authors:  Asako Itakura; Yumiko Tani; Naoko Kaneko; Michihiro Hide
Journal:  J Dermatol       Date:  2018-06-13       Impact factor: 4.005

View more
  9 in total

1.  Overall Impairment of Quality of Life in Japanese Patients with Hidradenitis Suppurativa: Comparison with National Standard.

Authors:  Koremasa Hayama; Hideki Fujita; Takashi Hashimoto; Tadashi Terui
Journal:  Acta Derm Venereol       Date:  2022-01-18       Impact factor: 3.875

2.  Hidradenitis Suppurativa International Online Community: Patient Characteristics and a Novel Model of Treatment Effectiveness.

Authors:  Jen Barak-Levitt; Ron Held; Yossi Synett; Noa Kremer; Emmilia Hodak; Shany Sherman
Journal:  Acta Derm Venereol       Date:  2022-04-04       Impact factor: 3.875

3.  Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients.

Authors:  Sylke Schneider-Burrus; Athanasia Tsaousi; Sebastian Barbus; Johannes Huss-Marp; Katrin Witte; Kerstin Wolk; Björn Fritz; Robert Sabat
Journal:  Front Med (Lausanne)       Date:  2021-04-27

4.  What's Race Got to Do With It? CRP Levels in Immune Mediated Skin Diseases: Considerations for Hidradenitis Suppurativa.

Authors:  Chidubem A V Okeke; Jonathan P Williams; Callyn U Iwuala; Pearl K Igwe; Raveena Khanna; Jessica D Perry; Ginette A Okoye; Angel S Byrd
Journal:  Front Immunol       Date:  2022-03-29       Impact factor: 7.561

5.  Quality of Life of Patients With Hidradenitis Suppurativa in Jeddah, Saudi Arabia.

Authors:  Awadh M Alamri; Abeer A Alzahrani; Anan M Aldakhil; Heba E Alharbi; Farah A Yahya
Journal:  Cureus       Date:  2021-12-07

6.  Similar Levels of Efficacy of Two Different Maintenance Doses of Adalimumab on Clinical Severity and Quality of Life of Patients with Hidradenitis Suppurativa.

Authors:  Luca Fania; Giulia Giovanardi; Tonia Samela; Dante Caposiena; Andrea Chiricozzi; Flaminia Antonelli; Pierluigi Saraceni; Fulvia Elia; Simone Garcovich; Davide Ciccone; Maria Vittoria Cannizzaro; Emanuele Miraglia; Chiara Iacovino; Sandra Giustini; Nevena Skroza; Alessandra Mambrin; Concetta Potenza; Luca Bianchi; Ketty Peris; Damiano Abeni
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

Review 7.  Phytotherapeuthics Affecting the IL-1/IL-17/G-CSF Axis: A Complementary Treatment Option for Hidradenitis Suppurativa?

Authors:  Katrin Witte; Robert Sabat; Ellen Witte-Händel; Kamran Ghoreschi; Kerstin Wolk
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

Review 8.  Quality of Life in Hidradenitis Suppurativa: An Update.

Authors:  Pavel V Chernyshov; Andrew Y Finlay; Lucia Tomas-Aragones; Francoise Poot; Francesca Sampogna; Servando E Marron; Sergey V Zemskov; Damiano Abeni; Thrasyvoulos Tzellos; Jacek C Szepietowski; Christos C Zouboulis
Journal:  Int J Environ Res Public Health       Date:  2021-06-06       Impact factor: 3.390

9.  Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?

Authors:  Piotr K Krajewski; Servando E Marrón; Lucía Tomas Aragones; Yolanda Gilaberte-Calzada; Jacek C Szepietowski
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.